MedImmune up as sources say Goldman hired Thu Apr 12, 2007 7:19am ET
NEW YORK (Reuters) - Shares of MedImmune Inc. (MEDI.O: Quote, Profile , Research) rose 3 percent before the bell on Thursday after sources told Reuters the biotechnology company had hired Goldman Sachs to help with a possible sale of the company. In consolidated electronic trading ahead of the opening bell, the stock was up $1.26 at $39 after closing Wednesday at $37.84 on Nasdaq. Based on Wednesday's closing price, the company has a market capitalization of about $8.8 billion. Its stock has not traded above $39 since August 2003.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.